Helsinn Investment Fund
VC
INVESTOR TYPE
Active
STATUS
11
INVESTMENTS
8
PORTFOLIO
2
EXITS
Description
Helsinn Investment Fund is the corporate venture arm of Helsinn Group. The firm focuses on privately-owned companies with early stage technologies in the oncology, biotechnology, pharmaceutical, medical devices and food supplements. It is based in Luxembourg, Luxembourg.
Website
Investor Status
Actively Seeking New Investments
Year Founded
2016
Primary Investor Type
Corporate Venture Capital
Other Investor Types
Venture Capital
Primary Office
- 412F, route d'Esch
- Luxembourg, 2086
- Luxembourg
Helsinn Investment Fund Investments (11)
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Company Stage | Lead Partner |
|---|---|---|---|---|---|---|
| Gain Therapeutics | 19-Feb-2019 | Early Stage VC | 00.000 | Drug Discovery | Generating Revenue | 00000000 0000000 |
| 0000 000000000000 | 12-Nov-2018 | 00000 00000 | 000.00 | Drug Discovery | Pre-Clinical Trials | 00000000 0000000 |
| 000000000000 | 01-Aug-2018 | 00000 00000 | 0000 | Biotechnology | Generating Revenue | |
| 0000000000 | 30-Apr-2018 | 00000 00000 | 000 | Biotechnology | Generating Revenue | 0000000 00 00000 |
| 00 000000 00000000 | 14-Mar-2018 | 00000 00000 | 0000 | Other Healthcare Technology Systems | Clinical Trials - Phase 2 | |
| 00000000 000000 00 | 04-Jan-2018 | 00000 00000 | 0000 | Biotechnology | Generating Revenue | |
| 000000000 00000 | 16-Jun-2017 | 00000 00000 | 00.00 | Other Devices and Supplies | Product Development | |
| 0000 | 08-May-2017 | 00000 00000 | 0000 | Biotechnology | Clinical Trials - Phase 2 | |
| OncoResponse | 23-Mar-2017 | Early Stage VC | 000.00 | Biotechnology | Generating Revenue | |
| QuantuMDx | 14-Dec-2016 | Later Stage VC | 000.00 | Laboratory Services (Healthcare) | Generating Revenue |
Request full access to PitchBook
You’re viewing a free company profile from the PitchBook Platform. To explore Helsinn Investment Fund’s full profile, request a free trial.
Helsinn Investment Fund Exits (2)
| Company Name | Exit Date | Exit Type | Exit Size | Status | Buyers |
|---|---|---|---|---|---|
| Amal Therapeutics | 15-Jul-2019 | Merger/Acquisition | 00000 | Completed |
|
| 000 000000 | 000000000 00000000 | Completed |
|
Helsinn Investment Fund Team (4)
Helsinn Investment Fund Co-Investors (44)
| Name | With | Exits | Lead Partner |
|---|---|---|---|
| Helsinn Healthcare | 4 | 0 | |
| Windham Venture Partners | 0 | 0 | |
| ARCH Venture Partners | 0 | 0 | |
| H.I.G. Capital | 0 | ||
| Vivo Capital | 0 | 0 |